SRSF5 Regulates the Expression of BQ323636.1 to Modulate Tamoxifen Resistance in ER-Positive Breast Cancer
Cited by 3
Related Papers
A novel missense mutation in <i>CCDC88C</i> activates the JNK pathway and causes a dominant form of spinocerebellar ataxia
|Journal of Medical Genetics|2014|73
Perturbation of U2AF65/NXF1-mediated RNA nuclear export enhances RNA toxicity in polyQ diseases
|Human Molecular Genetics|2011|50
Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer
|International Journal of Molecular Sciences|2022|6
The Splice Variant of the NCOR2 Gene BQ323636.1 Modulates ACSL4 Expression to Enhance Fatty Acid Metabolism and Support of Tumor Growth in Breast Cancer
|International Journal of Molecular Sciences|2025|3